GlassScriptPhysician profile
Kinloch Nelson
NPI 1023205739
$25,370.09
in general payments reported to CMS, 2019-2025
53 companies · $5,090 in 2025
The $5,090 reported for 2025 was more than what 91% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,922 · 2020: $1,422 · 2021: $2,610 · 2022: $3,062 · 2023: $6,143 · 2024: $4,122 · 2025: $5,090.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Consulting Fee: $3,522 · Education: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,666.78 |
| Consulting Fee | $3,522.00 |
| Education | $166.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $3,988.23 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $3,777.31 | 2019-2025 | Provenge |
| Janssen Biotech, INC. | $3,028.25 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Sumitomo Pharma America, INC. | $1,531.67 | 2023-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $1,514.06 | 2019-2025 | Xtandi |
| Astrazeneca Pharmaceuticals LP | $1,196.55 | 2020-2025 | Lynparza |
| Abbvie INC. | $961.86 | 2020-2025 | |
| Pfizer INC. | $940.39 | 2019-2025 | |
| Blue Earth Diagnostics | $853.47 | 2019-2025 | Posluma |
| Urogen Pharma, INC. | $680.46 | 2020-2025 | Jelmyto |
| Progenics Pharmaceuticals, INC. | $634.00 | 2022-2025 | Pylarify |
| Teleflex LLC | $578.21 | 2020-2025 | Urolift |
| Endo Pharmaceuticals INC. | $571.64 | 2019-2024 | Xiaflex, Aveed |
| Antares Pharma, INC. | $541.17 | 2019-2025 | Xyosted, Nocdurna, Tlando |
| Novartis Pharmaceuticals Corporation | $449.93 | 2022-2025 |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $416.59 | 2019-2020 | |
| Myovant Sciences INC. | $412.17 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $361.65 | 2020-2025 | Keytruda, Welireg, Lynparza |
| Urovant Sciences INC | $294.16 | 2021-2022 | |
| Endo USA, INC. | $282.04 | 2024-2025 | Xiaflex, Aveed |
| Amgen INC. | $216.07 | 2019-2023 | Prolia |
| Boston Scientific Corporation | $194.88 | 2019-2025 | Rezum Generator |
| Ferring Pharmaceuticals INC. | $178.88 | 2019-2025 | Adstiladrin |
| Calyxo, INC. | $169.57 | 2024-2025 | Cvac Aspiration System |
| Bioprotect Medical, INC. | $144.79 | 2024 | Bioprotect Balloon Implant System |
| Allergan, INC. | $135.66 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $135.43 | 2022-2025 | Yonsa |
| Rochester Medical Corporation | $113.63 | 2019-2022 | |
| Ambu INC. | $102.51 | 2022-2023 | |
| Accord Healthcare, INC. | $97.14 | 2022-2025 | |
| Tempus Ai, INC | $81.19 | 2024-2025 | Xt Cdx |
| Travere Therapeutics, INC. | $80.03 | 2019-2022 | |
| Procept Biorobotics Corporation | $66.33 | 2023-2024 | Aquabeam System, Aquabeam Robotic System |
| Clarus Therapeutics INC. | $62.36 | 2021 | |
| Halozyme INC | $61.44 | 2023 | |
| Alnylam Pharmaceuticals INC. | $57.53 | 2022-2023 | Givlaari |
| Bard Access Systems, INC. | $56.83 | 2019 | |
| Axonics, INC. | $43.26 | 2022-2023 | Axonics |
| Laborie Medical Technologies Corp. | $41.41 | 2024 | Endosheath Technology |
| C. R. Bard, INC. & Subsidiaries | $40.24 | 2019-2023 | Bard Urinary Drainage Bag |
| Photocure INC | $36.34 | 2019 | |
| Mission Pharmacal Company | $33.42 | 2019 | |
| Tolmar, INC. | $30.00 | 2024 | |
| Janssen Pharmaceuticals, INC | $27.18 | 2019-2021 | |
| Olympus America INC. | $22.19 | 2025 | Itind System |
| Genzyme Corporation | $21.83 | 2023 | |
| Cardinal Health 414 LLC | $18.89 | 2022 | |
| Foundation Medicine, INC. | $17.60 | 2021 | |
| Baxter Healthcare | $14.84 | 2019 | |
| Coloplast Corp | $14.70 | 2022 | |
| Myriad Genetic Laboratories, INC. | $14.44 | 2021 | |
| Immunitybio, INC. | $13.57 | 2025 | |
| Clovis Oncology, INC. | $12.10 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kinloch Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.